PU processor Recticel (Brussels / Belgium; www.recticel.com) has agreed to sell its remaining 50.6% stake in its joint venture subsidiary Corpura for EUR 2.3m to wound care dressing technologies specialist Advanced Medical Solutions (AMS, Winsford, Cheshire / UK; www.admedsol.com). Recticel and AMS entered into a jv in June 2008 when AMS acquired 49.4% of Corpura – see Plasteurope.com of 02.06.2008. Following the transaction, AMS will fully own Corpura, which was established in 2004 as part of Recticel’s flexible foams business. The company produces hydrophilic polyurethane at its dedicated R&D and manufacturing facility in Etten-Leur / The Netherlands. It employs 15 people and reported sales of EUR 3.3m.

Corpura presently supplies AMS with polyurethane foam for inclusion into its advanced wound care dressings. Hydrophilic polyurethane foam is used in the advanced wound care market where it is considered an ideal material for the treatment of medium to high exudate chronic wounds and for delivery of active technologies to prevent infection and help accelerate wound healing.